Improving the Armamentarium of PI3K Inhibitors with Isoform-Selective Agents: A new Light in the Darkness

被引：24
|
作者：
Rodon, Jordi [1 ]
Tabernero, Josep [2 ,3 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Invest Canc Therapeut, Houston, TX 77030 USA
[2] Vall Hebron Univ Hosp, Med Oncol Dept, Barcelona, Spain
[3] VHIO, Barcelona, Spain
来源：
CANCER DISCOVERY | 2017年 / 7卷 / 07期
关键词：
RESISTANCE; CANCER;
D O I：
10.1158/2159-8290.CD-17-0500
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Excitement and drug-development efforts aimed at targetable genetic aberrations in the PI3K/AKT/mTOR pathway have declined due to the limited clinical performance of these inhibitors as monotherapies. New, more isoform-selective treatments, such as taselisib, promise to both expand the therapeutic window and increase efficacy. (C) 2017 AACR.
引用
收藏
页码：666 / 669
页数：4
相关论文
共 50 条
  • [1] PI3K Isoform-Selective Inhibitors in Cancer
    Duncan, Leslie
    Shay, Chloe
    Teng, Yong
    [J]. SINGLE-CELL SEQUENCING AND METHYLATION: METHODS AND CLINICAL APPLICATIONS, 2020, 1255 : 165 - 173
  • [2] Isoform-Selective PI3K Inhibitors for Various Diseases
    Bheemanaboina, Rammohan R. Y.
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2020, 20 (12) : 1074 - 1092
  • [3] Isoform-selective targeting of PI3K: time to consider new opportunities?
    Cirillo, Davide
    Diceglie, Marta
    Nazare, Marc
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2023, 44 (09) : 601 - 621
  • [4] PI3K isoform-selective inhibitors: next-generation targeted cancer therapies
    Xiang Wang
    Jian Ding
    Ling-hua Meng
    [J]. Acta Pharmacologica Sinica, 2015, 36 : 1170 - 1176
  • [5] PI3K isoform-selective inhibitors: next-generation targeted cancer therapies
    Wang, Xiang
    Ding, Jian
    Meng, Ling-hua
    [J]. ACTA PHARMACOLOGICA SINICA, 2015, 36 (10) : 1170 - 1176
  • [6] Isoform-selective PI3K inhibitors as novel therapeutics for the treatment of acute myocardial infarction
    Doukas, J.
    Wrasidlo, W.
    Noronha, G.
    Dneprovskaia, E.
    Hood, J.
    Soll, R.
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 : 204 - 206
  • [7] L-Aminoacyl-triazine Derivatives Are Isoform-Selective PI3Kβ Inhibitors That Target Nonconserved Asp862 of PI3Kβ
    Pinson, Jo-Anne
    Zheng, Zhaohua
    Miller, Michelle S.
    Chalmers, David K.
    Jennings, Ian G.
    Thompson, Philip E.
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (02): : 206 - 210
  • [8] A deep learning-based theoretical protocol to identify potentially isoform-selective PI3Kα inhibitors
    Shafiq, Muhammad
    Sherwani, Zaid Anis
    Mushtaq, Mamona
    Nur-e-Alam, Mohammad
    Ahmad, Aftab
    Ul-Haq, Zaheer
    [J]. MOLECULAR DIVERSITY, 2024,
  • [9] Combination studies using PI3K isoform-selective inhibitors in PTEN-deficient cancer cells
    Blackwell, Christina
    De Young, M. Phillip
    [J]. CANCER RESEARCH, 2016, 76
  • [10] Synergistic effects of connexin 43 inhibitor and PI3K isoform-selective inhibitors in temozolomide-resistant glioblastoma
    Hutchings, Kasen R.
    Pridham, Kevin J.
    Liu, Min
    Owens, Joseph
    Sheng, Zhi
    [J]. CANCER RESEARCH, 2022, 82 (12)
12345